Esen K. Akpek, MD Date: DEMOGRAPHIC INFORMATION … · DEMOGRAPHIC INFORMATION ... Johns Hopkins...
Transcript of Esen K. Akpek, MD Date: DEMOGRAPHIC INFORMATION … · DEMOGRAPHIC INFORMATION ... Johns Hopkins...
1
Signature
Name: Esen K. Akpek, MD Date: 1/5/2011
DEMOGRAPHIC INFORMATION
Current Appointments:
Johns Hopkins University School of Medicine, Johns Hopkins Hospital.
Johns Hopkins University School of Medicine, Bayview Medical Center.
Personal Data:
Business address: The Wilmer Eye Institute
Johns Hopkins Medical Institutions
600 N. Wolfe Street, Maumenee #317
Baltimore, MD 21287
Telephone: (410) 955 5214
Fax: (410) 614 6480
e-mail: [email protected]
Education:
1990-1991 BS, Ankara Girls’ Lycee, Ankara, Turkey
1984-1985 English Preparatory School at Hacettepe
University Medical School, Ankara
1985-1990 MD, Hacettepe University Medical School, Ankara
Postdoctoral Training:
1990-1992 Intern in medicine, Hacettepe University
Medical School Hospital and Children’s
Hospital, Ankara
1992-1995 Residency in ophthalmology, Ankara Numune
Hospital, Ankara
2/1996-6/1996 Research fellow, Hilles Immunology Laboratory, Department
of Ophthalmology, Massachusetts Eye and Ear Infirmary,
Harvard Medical School, Boston
7/1996-6/1998 Clinical fellow, Ocular Immunology and Uveitis Service,
Department of Ophthalmology, Massachusetts Eye and Ear
Infirmary, Harvard Medical School, Boston
7/1998-6/1999 Clinical fellow, Cornea and External Disease Service,
Wilmer Eye Institute Department of Ophthalmology,
Johns Hopkins University School of Medicine, Baltimore
2
Professional Experience:
1991-1992 General practitioner, Social Security Hospital, Ankara,
Turkey
1994-1995 Chief Resident in ophthalmology, Ankara Numune Hospital,
Ankara
1999-2000 Instructor in ophthalmology, Wilmer Eye Institute, Johns
Hopkins University Medical School, Baltimore
2000-2005 Assistant Professor in ophthalmology, Cornea and External
Disease Service, Wilmer Eye Institute, Johns Hopkins
University Medical School, Baltimore
2004-present Director, Ocular Surface Diseases and Dry Eye Clinic,
Wilmer Eye Institute, Johns Hopkins University Medical
School, Baltimore
2005-present Associate Professor of Ophthalmology, Cornea and External
Disease Service, Wilmer Eye Institute, Johns Hopkins
University Medical School, Baltimore
2009-present Associate Director of Sjogrens’ Syndrome Center, Johns
Hopkins at Bayview Medical Center, Baltimore, Maryland
2010-present Director, Cornea and External Disease Clinical Fellowship,
Wilmer Eye Institute, Johns Hopkins University Medical
School, Baltimore, Maryland
2011-present Associate Professor of Rheumatology,
RESEARCH ACTIVITIES
Publications:
Peer-reviewed scientific articles:
1. Utine CA, Tzu J, Akpek EK. Lamellar keratoplasty using gamma irradiated
corneal lenticules. Am J Ophthalmol 2011;151:170-174.
2. Zhang K, Akpek EK, Weblinger VP, et al. Noninvasive quality evaluation of
post-surgical clear corneal insicion via high resolution Fourier-domain optical
coherence tomography. Electronics Letters 2010;46;22.
3. Utine CA, Gehlbach PL, Zimmer-Galler I, Akpek EK. Permanent
Keratoprosthesis Combined With Pars Plana Vitrectomy and Silicone Oil
Injection for Visual Rehabilitation of Chronic Hypotony and Corneal Opacity.
Cornea 2010;Epub ahead of print.
4. Karp JK, Akpek EK, Anders RA. Autoimmune hepatitis in patients with
primary Sjogren’s syndrome: a series of two–hundred and two patients. In J Clin
Exp Pathol 2010;3:582-6.
5. Tay E, Utine CA, Akpek EK. Crescenteric amniotic membrane grafting in
keratoprosthesis-associated corneal melt. Arch Ophthalmol. 2010;128:779-82.
6. Dunlap K, Chak G, Aquavella JV, Myrowitz E, Akpek EK. Short-Term Visual
Outcomes of Boston Type 1 Keratoprosthesis Implantation. Ophthalmology
2010;117:687-92.
3
7. Tzu JH, Desai NR, Akpek EK. Use of a microvascular clip for iris fixation of
an intraocular lens: a laboratory model. Arch Ophthalmol. 2010;128:114-6.
8. Akpek EK, Vittitow J, Verhoeven RS, et al. Ocular surface distribution and
pharmacokinetics of a novel ophthalmic 1% azithromycin formulation. J Ocul
Pharmacol Ther. 2009;25:433-9.
9. Ali FS, Akpek EK. Dry eye and glaucoma. Ophthalmology 2009;116:1232.
10. Akpek EK, Klimava A, Thorne JE, et al. Evaluation dry eye patients for
associated medical conditions. Cornea. 2009;28:493-7.
11. Gupta A, Sadeghi PB, Akpek EK. Occult thyroid eye disease in patients
presenting with dry eye symptoms. Am J Ophthalmol 2009;147:919-23.
12. Shan SJ, Wu EI, Akpek EK. Sterile corneal melt after descemet stripping
endothelial keratoplasty in patients with previously undiagnosed Sjogren
syndrome. Arch Ophthalmol 2009; 127: 219-20.
13. Adyanthaya RS, Folgar FA, Akpek EK. Medical management of acutely
recurring pterygium with topical mitomycin C. J Cataract Refract Surg
2009;35:200-2.
14. Jabs DA, Prendergast RA, Lee B, Akpek EK, et al. Autoimmune Th2-mediated
dacryoadenitis in MRL/MpJ mice becomes Th1-mediated in IL-4 deficient
MRL/MpJ mice. Invest Ophthalmol Vis Sci 2007;48:5624-9.
15. Coassin M, Zhang C, Green WR, Aquavella JA, Akpek EK. Histopathological
and immunohistochemical aspects of artificial corneal failure. Am J
Ophthalmol 2007;144:699-704.
16. Parekh P, Green WR, Stark WJ, Akpek EK. Electron microscopic investigation
of the lens capsule and conjunctival tissues in individuals with clinically
unilateral pseudoexfoliation syndrome. Ophthalmology 2007;114:
17. Akpek EK, Harissi-Dagher M, Petrarca R, Butrus SA, Pineda R, Aquavella JV,
Dohlman CH. Outcomes of boston keratoprosthesis in aniridia: a retrospective
multicenter study. Am J Ophthalmol, 2007;144:227-231.
18. Aquavella JV, Gearinger MD, Akpek EK, McCormick GJ. Pediatric
keratoprosthesis. Ophthalmology 2007;114:989-94.
19. Parekh P, Stark W, Green WR, Akpek EK. Subluxation of Suture-Fixated
Posterior Chamber Intraocular Lenses: A Clinicopathological Study.
Ophthalmology 2007;114:232-7
20. Pakravan M, Klesert T, Akpek EK. Conjunctival lichen planus. Br Journal
Ophthalmol, 2006;90:1325-6.
21. Bothelho PJ, Congon NG, Handa JT, Akpek EK. Keratoprosthesis in High-Risk
Pediatric Corneal Transplantation: First Two Cases. Arch Ophthalmol,
2006;124:1356-7.
22. Ilhan-Sarac O, Akpek EK. Current concepts and techniques in keratoprosthesis.
Curr Opin Ophthalmol 2005;16:246-50.
23. Tatlipinar S, Akpek EK. Topical Cyclosporin A in the Treatment of Ocular
Surface Diseases: An Evidence Based Review. Br J Ophthalmol
2005;89:1363-7.
24. Jabbur NS, Akpek EK, Stark WJ. Subluxation of iris-sutured intraocular lenses
and results of a closed chamber technique for repositioning. Cornea
2005;24:438-42.
4
25. Jabs DA, Akpek EK. Immunosuppression for posterior uveitis. Retina
2005;25:1-18.
26. Akpek EK, Chan CC, Shen D, Green WR. Lack of herpetic viral etiology in the
choroidal tissues of a patient with serpiginous choroiditis. Ophthalmology
2004;111:2071-5.
27. Jabs DA, Gérard HC, Prendergast RA, Wang WY, Hudson AP, Akpek EK, et
al. Inflammatory mediators in autoimmune lacrimal gland disease in MRL/MPj
mice. Invest Ophthalmol Vis Sci 2004;45:2293-8.
28. Akpek EK, Watson S, Christen W, et al. A randomized, placebo-controlled trial
of topical cyclosporin 0.05% in steroid resistant atopic keratoconjunctivitis.
Ophthalmology 2004;111:476-82.
29. Akpek EK, Thorne JE, Qazi FA, et al. Evaluation of patients with scleritis for
systemic disease. Ophthalmology 2004;111:501-06.
30. Akpek EK, Jabs DA, Whittum-Hudson JA, et al. Chemokines in autoimmune
lacrimal gland disease in MRL/MPJ mice. Invest Ophthalmol Vis Sci,
2004;45:185-90.
31. Akpek EK, Gottsch JD. Ocular surface immune defense. Eye, 2003;17:949-56.
32. Akpek EK, Ilhan-Sarac O, Green WR. Topical cyclosporin in the treatment of
chronic sarcoidosis of the conjunctiva. Arch Ophthalmol 2003;121:1333-5.
33. Akpek EK, Ilhan-Sarac O. New treatments for serpiginous choroiditis.
Curr Opin Ophthalmol. 2003;14:128-31.
34. Akpek EK, Altan-Yaycioglu R, Karadayi K, et al. Long-term outcomes of
combined penetrating keratoplasty with iris sutured intraocular lens
implantation. Ophthalmology 2003;110:1017-22.
35. Akpek EK, Jabs DA, Tessler HH, Joondeph BA, Foster CS. Successful
treatment of serpiginous choroiditis with alkylating agents. Ophthalmology
2002;109:1506-13.
36. Akpek EK, Liu SH, Thompson R, Gottsch JD. Experimental helminthic
keratitis induced by paramyosin-calgranulin C (HuCOAg) complex. Invest
Ophthalmol Vis Sci 2002;43:2677-84.
37. Jun AS, Broman K, Van Do D, Akpek EK, Stark WJ, Gottsch JD. Endothelial
dystrophy, iris hypoplasia, congenital cataracts, and stromal thinning (EDICT)
syndrome maps to chromosome 15q15-q25. Am J Ophthalmol 2002;134:172-
6. 38. Akpek EK, Jun AS, Goodman DF, Green WR, Gottsch JD. Clinical and
ultrastructural features of a novel hereditary anterior segment dysgenesis.
Ophthalmology 2002;109:513-9.
39. Akpek EK, Baltatzis S, Yang J, Foster CS. Long-term immunosuppressive
treatment in serpiginous choroiditis. Ocul Immunol Inflamm 2001;9:153-68.
40. Akpek EK, Altan-Yaycioglu R, Stark WJ. Spontaneous corneal perforation in a
patient with unusual unilateral pellucid marginal degeneration. J Cataract
Refract Surg 2001;27:1698-1700.
41. Akpek G, Akpek EK, Lee S, et al. Unusual locations for lymphomas: case 3.
Successive occurrence of peripheral T-cell lymphoma with bilateral conjunctival
involvement in a patient with low-grade B-cell lymphoma. J Clin Oncol
2001;19:2964-6.
5
42. Akpek EK, Liu SH, Gottsch JD. Induction of experimental autoimmune
keratitis by adoptive transfer of human corneal antigen-specific T cell line.
Invest Ophthalmol Vis Sci 2000; 41:4182-8. 43. Gottsch JD, Akpek EK. Topical cyclosporin stimulates neovascularization in
resolving sterile rheumatoid central corneal ulcers. Trans Am Ophthalmol Soc
2000;98:59-69.
44. Akpek EK, Gottsch JD. Herpes zoster sine herpete presenting with hyphema.
Ocul Immunol Inflamm 2000;8:115-8.
45. Akpek EK, Demetriades AM, Gottsch JD. Peripheral ulcerative keratitis
following clear corneal cataract extraction. J Cataract Refract Surg
2000;26:1424-7.
46. Nguyen QD, Uy HS, Akpek EK, Harper S, Zacks D, Foster CS. Choroidopathy
of systemic lupus erythematosus. Lupus 2000;9:288-98. 47. Akpek EK, Haddad RS, Winkelstein JA, Gottsch JD. Bilateral consecutive
central corneal perforations associated with hypogammaglobulinemia.
Ophthalmology 2000;107:123-6.
48. Akpek EK, Hasiripi H, Christen WG, Kalayci D. A randomized trial of low-
dose, topical mitomycin-C in the treatment of vernal keratoconjunctivitis.
Ophthalmology 2000;107:263-9.
49. Akpek EK, Maca SM, Foster CS. Elevated vitreous interleukin-10 level is not
diagnostic of intraocular-central nervous system lymphoma. Ophthalmology
1999;106:2291-5.
50. Sangwan W, Akpek EK, Zhao TZ, Pinar V, Yang J, Foster CS. Krill protease
effects on wound healing following corneal alkali-burn. Cornea 1999;18:707-
11.
51. Akpek EK, Ahmed I, Hochberg HF, Soheilian M, Dryja TP, Jakobiec FA,
Foster CS. Primary intraocular lymphoma: clinical features, diagnosis and
outcomes. Ophthalmology 1999;106:1805-10. (Selected to be included in the
Year Book of Ophthalmology, Wilson RP (ed), 2000;266-7.)
52. Akpek EK, Polcharoen W, Chan R, Foster CS. Ocular surface neoplasia
masquerading as chronic blepharoconjunctivitis. Cornea 1999;18:282-8.
53. Akpek EK, Polcharoen W, Ferry JA, Foster CS. Conjunctival lymphoma
masquerading as chronic conjunctivitis. Ophthalmology 1999;106:757-60.
54. Akpek EK, Uy H, Christine W, Gurdal C, Foster CS. Severity of episcleritis
and systemic disease association. Ophthalmology 1999;106:729-31.
55. Akpek EK, Kent C, Jakobiec FA, Caliendo AM, Foster CS. Bilateral acute
retinal necrosis caused by cytomegalovirus in an immunocompromised patient.
Am J Ophthalmol 1999;127:93-5.
56. Akpek EK, Ertoy D, Kalayci D, Hasiripi H. Post-operative topical mitomycin-C
in conjunctival squamous cell neoplasia. Cornea 1999;18:59-62.
57. Akpek EK, Merchant A, Pinar V, Foster CS. Ocular rosacea: patient
characteristics and follow-up. Ophthalmology 1997;104:1873-7. (Selected to
be included in the Year Book of Dermatology, Thiers BH, Lang PG (eds),
1998;155-7.)
58. Akpek EK, Ertoy D, Aslan Y, Recep OF, Hasiripi H. Invasive squamous cell
carcinoma of the conjunctiva: a case report. Ann Ophthalmol 1996;28:364-6.
6
59. Kalaycı D, Bascı N, Akpek EK, Hasıripi H, Bozkurt A. Penetration of topical
0.3% ciprofloxacin into human aqueous humor. Ophthalmic Surg Lasers
1996;27:21-4.
In press:
60. Akpek EK, Lindsley K, Adyanthaya RS, Swamy R, Baer AN, McDonnell PJ.
Treatment of Sjögren’s syndrome-associated dry eye: An evidence-based
review. Ophthalmology.
Submitted:
61. Tzu JH, Utine CA, Stern M, Akpek EK. Topical cyclosporine 0.05% as a long-
Term monotherapy for atopic keratoconjunctivitis. Cornea
62. Utine CA, Tzu J, Akpek EK. Clinical features and outcomes of Boston type I
keratoprosthesis associated corneal melt. Acta.
63. Utine CA, Swamy R, Thorne JE, Baer AN, Akpek EK. Diagnosis of Sjogren’s
syndrome in patients presenting with dry eye. Ophthalmology.
64. Swamy R, Utine CA, Thorne JE, Baer AN, Akpek EK. Predictors of Sjogren’s
syndrome in patients presenting with dry eye. Ophthalmology.
65. Dokey A, Akpek EK. Chronic hypotony associated with Boston type 1
keratoprosthesis. Cornea.
66. Kpro aphakic vs pseudophakic Ophthalmology
Non-peer-reviewed articles:
1. Akpek EK. Evaluation of Patients With Dry Eye for Presence of Underlying Sjögren
Syndrome: author’s reply. Cornea. 2010 Jun 23.
2. Akpek EK, Kalayci D. Mitomycin-C and vernal conjunctivitis: authors’ reply.
Ophthalmology 2000;107:2126.
3. Akpek EK, Kalayci D. Mitomycin-C and vernal conjunctivitis: authors’ reply.
Ophthalmology 2000;107:2126-7.
4. Akpek EK, Foster CS. Elevated vitreous interleukin-10 level is not diagnostic of
intraocular-central nervous system lymphoma: authors’ reply. Ophthalmology
2001;108:426-7.
5. Foster CS, Akpek EK. Elevated vitreous interleukin-10 level is not diagnostic of
intraocular-central nervous system lymphoma: authors’ reply. Ophthalmology
2001;108:428.
6. Akpek EK, Foster CS. Primary intraocular lymphoma with a low interleukin 10 to
interleukin 6 ratio and heterogeneous IgH gene arrangement: letter to the editor. Arch
Ophthalmol 2000;118:731-2.
7. Akpek EK, Karadayi K. Ketorolac tromethamine 0.5% ophthalmic solution in the
treatment of moderate to severe ocular inflammation after cataract surgery: a
randomized, vehicle-controlled clinical trial: letter to the editor. Am J Ophthalmol
1999;128:662-3.
Book chapters:
1. Akpek EK, Gottsch JD. Mooren’s ulcer, in Current Ocular Therapy, 5th edition. Eds
Fraunfelder and Roy. WB Saunders Publishers, New York, 1999;367-9.
7
2. Akpek EK, Foster CS. Limbal stem cell transplantation, in Surgical Advances in
Ophthalmology. Eds Jakobiec FA, Kryzstolic M. Lippincott, Williams and Wilkins,
Philadelphia, 1999; 39(1);71-82.
3. Akpek EK, Irkec M. Allergic conjunctivitis, in Cornea and External Disease: The
Essentials. Eds McDonnell P, O’Brien TP. Thieme Medical Publishers, Inc, New
York, in press.
4. Akpek EK, Altan-Yaycioglu R, Stark WJ. Six pearls in challenging corneal surgery,
in 101 Pearls in Cataract, Refractive and Corneal surgery. Eds. Melki SA, Azar DT.
Slack Incorporated, Thorofare, NJ, 2001;149-60.
5. Akpek EK, Altan-Yaycioglu R, Stark WJ. Corneal stability and biomechanics after
LASIK, in LASIK. Eds Azar DT, Koch DD. Marcel Dekker, Inc, New York,
2002;163-72.
6. Akpek EK, Ilhan-Sarac O. Cicatrizing conjunctivitis, in Smolin and Thoft’s The
Cornea, 4th edition. Eds Foster CS, Azar DT, Dohlman C. Lippincott Williams and
Wilkins, Philadelphia.
7. Akpek EK, Jabbur NS, Daines BS, Stark WJ. Corneal ectasia after LASIK, in
Myopia and Related Diseases: A Clinical and Therapeutic Approach. Midena E. Ed.
Fondazione G.B. Bietti per lo Studio e la Ricerca in Oftalmologia ONLUS,
Ophthalmic Communications Society, Inc., New York, 2005; 443-448.
8. Daines BS, Akpek EK, Jabbur NS, Stark WJ. Update on phakic intraocular lenses, in
Myopia and Related Diseases: A Clinical and Therapeutic Approach. Midena E. Ed.
Fondazione G.B. Bietti per lo Studio e la Ricerca in Oftalmologia ONLUS
Ophthalmic Communications Society, Inc., New York, 2005; 453-459.
9. Sen N, Eser I, Akpek EK. Lamellar keratoplasty in perforated pellucid marginal
degeneration. Section V: Tectonic lamellar keratoplasty. In: Surgical Techniques in
anterior and posterior lamellar corneal surgery. Ed: Thomas John. Jaypee Brothers
Medical Publishers (P) LTD, New Delhi, 2005;469-476.
10. Jabs DA, Akpek EK. Immunosuppressive therapy for posterior segment disease.
Retina, 4th edition. Editor in Chief: Stephen Ryan. Elsevier, London, 2005.
11. Suh L, Akpek EK, Stark WJ. Tectonic lamellar keratoplasty in Mooren’s and
Mooren’s-like corneal ulcers. Section V: Tectonic lamellar keratoplasty. In: Surgical
Techniques in anterior and posterior lamellar corneal surgery. Ed: Thomas John.
Jaypee Brothers Medical Publishers (P) LTD, New Delhi, 2005;483-490.
12. Tatlipinar S, Akpek EK. Scleritis. In: Current Ocular therapy 6th edition. Eds: F
Hampton Roy, Frederick T Fraunfelder, Frederick W Fraunfelder. Elsevier. Chapter
347, pp 653-656.
13. Lekhanont K, Panday V, Akpek EK. Permanent Keratoprostheses. Part V, Special
Situations in Corneal Surgery. In: Corneal Surgery, Theory, Technique and Tissue 4th
edition. Eds: F Brightbill, P J McDonnell, C N J McGhee. Assoc Ed: A A Farjo.
Elsevier. China, 2009. Chapter 78, pp 683-690.
14. Marangoz D, Akpek EK. Behcet Hastaligi. Uveit Kitabi. Akduman L and Aydin P,
eds. Gunes Tip Kitap Evleri, pages 171-182, Ankara, 2007.
15. Suh L, Akpek EK. Corneal Gluing. In: Basic Techniques of Ophthalmic Surgery.
Eds: JP. Dunn, PD. Langer. American Academy of Ophthalmology. San Francisco,
2009. Chapter 5, pp 34-37.
8
16. Srikumaran D, Tzu JH, Akpek EK. Cicatrizing Conjunctivitis. Focal
Points, Clinical Modules for Ophthalmologists. San Francisco, CA:
American Academy of Ophthalmology. 2010:29(1):1-9.
17. Dokey A, Akpek EK. "Aqueous tear deficiency and Sjogren´s syndrome". Atlas
and Text of Corneal Pathology and Surgery, English Edition. Eds: S Boyd, AM
Gutierrez, JP McCulley editors. Jaypee Highlights Medical Publishers, 2011, 7:81-92.
18. Gupta A, Akpek EK. What are the indications and contraindications for the use of
periocular corticosteroid injections? Curbside uveitis.
19.
Other media:
1. Akpek EK. Behcet’s Disease: an overview. Ocular Immunology website,
www.immunology.meei.harvard.edu. January 1997.
2. Akpek EK. Peripheral ulcerative keratitis associated with acne rosacea. Ocular
Immunology website, www.immunology.meei.harvard.edu. March 1997.
3. Akpek EK. Necrotizing scleritis: diagnosis and therapy. Ocular Immunology
website, www.immunology.meei.harvard.edu. November 1996.
4. Akpek EK. Allergic conjunctivitis. Ocular Immunology website,
www.immunology.meei.harvard.edu. May 1998.
5. Akpek EK. Conjunctival sebaceous cell carcinoma masquerading as chronic
conjunctivitis. Ocular Immunology website, www.immunology.meei.harvard.edu.
June 1998.
6. Akpek EK, Gottsch JD. Basic Immunology. www.yourdoctor.com.
7. Akpek EK, Weinberg R. Behcet’s disease, Patient Monograph. American Uveitis
Society website, www.aus.org
8. Altan-Yaycioglu R, Akpek EK, Stark WJ: Improvement of Corneal Opacity in
Peters' Anomaly . The Internet Journal of Ophthalmology and Visual Science. 2004.
Volume 3 Number 1.
http://www.ispub.com/ostia/index.php?xmlFilePath=journals/ijovs/vol3n1/peter.xml
9. Wu I, Akpek EK. Blepharitis.
https://online.epocrates.com/u/2911574/Blepharitis/Summary/Highlights
Extramural Sponsorship:
Grants:
1999-2002 Unrestricted clinical research grant from Allergan, Inc; Co-
Principal Investigator (75% effort); “Topical Cyclosporin in
the Treatment of Anterior Segment Inflammatory Diseases”
(total cost $142,400)
2004 Research to Prevent Blindness, William and Mary Greve
special scholar, for “Immunopathology of Atopic
Keratoconjunctivitis” ($ 60,000)
2004-2011 Principal Investigator (20% effort); “Effects of Topical
Cyclosporin Therapy in the Immunopathology of Atopic
9
Keratoconjunctivitis” from Allergan, Inc., ($90,000/ current
year, total direct cost $422,000)
2004 Director’s Discovery Fund, The Wilmer Eye Institute,
Principle Investigator (1% effort) “Keratoprosthesis in
Children with Congenital Anterior Segment Anomalies” ($
10,000)
2006-2007 Principle Investigator; Keratoprosthesis, from WL Gore
Assoc., ($78,000) (40% effort)
2009 Principal Investigator (1% effort) “A Phase I/II Prospective,
Randomized, Double Masked, Vehicle And Comparator
Controlled, Dose Ranging Study Of Cp-690,550 In Subjects
With Dry Eye Disease” ($78,117), sponsored by Pfizer Inc.
2009 Principal Investigator (1% effort) “A Multi-Center,
Prospective, Observational Study of the Progression of
Ocular Findings in Patients with Dry Eye Disease” ($78,
330), sponsored by Allergan Inc.
2009 Principal Investigator (1% effort) “A Randomized, Multi-
Center, Double-Masked, Placebo-Controlled, Parallel-Group
Safety and Efficacy Study of Azithromycin Ophthalmic
Solution 1% versus Placebo for Two Weeks in Subjects with
Blepharitis” ($42,300), sponsored by Inspire
Pharmaceuticals, Inc. (National Chair of the Study
Committee)
2009 Principal Investigator (1% effort) “A Multi-Center,
Randomized, Double-Masked, Parallel-Group Study
Evaluating the Efficacy and Safety of Cyclosporin
Ophthalmic Solution 0.010% Compared with Its Vehicle
Administered QID for 3 Months Followed by a 9 Month
Open-Label Phase in Patients with Atopic
Keratoconjunctivitis” ($117, 046), sponsored by Allergan
Inc. (National Chair of the Study Committee)
2009-2013 Co-Principle Investigator (10% effort) “International
Sjogren's Syndrome Registry”, (total cost $825,352),
sponsored by NIH
EDUCATIONAL ACTIVITIES
Teaching:
Classroom instruction:
1996-1998 Corneal Wound Healing, Immunology Seminars (one-hour
lecture, given once a year to the basic scientists and
students), Massachusetts Eye and Ear Infirmary, Harvard
Medical School.
1996-1998 Clinical Immunology Series (five half-hour lectures)
Massachusetts Eye and Ear Infirmary, Harvard Medical
School, (see www.uveitis.org for the titles and texts).
10
2002-2004 Eye and Systemic Disease (one-hour lecture); part of one-
week required clerkship for Johns Hopkins medical students.
2002-2005 Clinicopathologic Correlations (two-hour review on
conjunctivitis, keratitis, sarcoid and angle closure glaucoma),
Eye section of the Year 2 curriculum, Johns Hopkins medical
students.
2003-2010 Cataract, Refractive Surgery and Red Eye (Year 2 and 3
Johns Hopkins Medical Students)
2003-present Residency core lectures (four one-hour lectures per year):
Immune-Mediated Disorders of the Eyelid & Conjunctiva,
Ocular Surface Disorders: Dermatoses, Structural &
Exogenous Disorders, Ocular Surface Disorders: Dry Eye,
Nutritional & Physiologic Disorders, Ocular Herpetic
Infections for Wilmer Eye Institute resident
ophthalmologists.
2006-present Cornea, Cataract, External Diseases, Refractive Surgery Bi-
Monthly Journal Clubs (for Wilmer Eye Institute residents as
well as Cornea Fellows)
2007-2009 Ocular Allergy (one hour lecture as part of required
classroom lecture series for Allergy Immunology Clinical
Fellows at Bayview Allergy Immunology Center)
Clinical instruction:
2002-present Clinical preceptorship (eight half-days per year), part of the
required one-week clerkship of 3rd and 4th year Johns
Hopkins medical students.
2002-present Clinical skills sessions (two-hour hands-on course on
ophthalmology examination techniques), 2nd year Johns
Hopkins medical student education.
2004-present Clinical Patient Practicum. A two hour practical course on
ophthalmology examination techniques, part of required
Ophthalmology Clerkship curriculum, 3rd
and 4th year Johns
Hopkins medical student education.
2002-present Clinical preceptorship (one full day per week at the Wilmer
Eye Institute, Johns Hopkins Medical School), 2nd year
ophthalmology residents.
2002-present Surgical preceptorship (one full day per week with second
year residents, and two full days per month with the 3rd year
ophthalmology residents), Wilmer Eye Institute, Johns
Hopkins Medical School.
2002-present Surgical and clinical preceptorship, as part of Cornea and
External Diseases Fellowship Program (One full day per
week in the operating room and one full day per week in the
clinic).
Research instruction:
11
2002-present Research preceptorship, “Clinical/basic research in cornea
and external eye disease,” a six-week medical student
elective, for Johns Hopkins medical students and foreign
medical students (typically one or two medical students
during the spring-summer).
2000-present Research preceptorship (research related to allergic and
immunologic ocular surface diseases), postdoctoral Fellows,
mainly from outside the USA (typically one or two fellows
per year).
CME instruction:
2000 Course Instructor, Cornea Day, Wilmer Eye Institute,
Baltimore, Maryland
2000-2006 Course Instructor, annual Wilmer Ophthalmological Institute
Clinical Meeting, Baltimore, Maryland.
2001-present Course Instructor in annual “Current Concepts in
Ophthalmology” course, Baltimore, Maryland.
2002-2007 Course Instructor in annual “Ophthalmology for the Medical
Practitioner”, Baltimore, Maryland.
2002-present Course Instructor, International Ocular Inflammation Society
Meeting, held every other year in various European
countries.
2003-present Course Instructor in Biannual Uveitis 2003 Subspecialty
Day, in conjunction with the American Academy of
Ophthalmology.
2004-2009 Participant in International Ocular Inflammation Society
Continuous Medical Education Program.
2005-present Course Instructor (with Dr. Parekh), Joint Commission on
Allied Health Personnel in Ophthalmology, in conjunction
with the annual American Academy of Ophthalmology.
Infiltrates and inflammatory ulcers of the cornea (05SA5)
2007 Course Instructor, “Managing Concomitant Eye Diseases: An
Experts’ View on Glaucoma and Dry Eye” Epidemiology of
Dry Eye and Glaucoma, November, 2007
2006-present Course Instructor, Wilmer Annual Ophthalmic Technician
Course, “Herpetic Keratoconjunctivitis”.
2008-present Course Instructor, “The Boston Keratoprosthesis: What You
Don’t Know Will Surprise You”, at the Annual Academy of
Ophthalmology Meeting
2008-present Course Instructor, Wilmer Annual Ophthalmic Nurses
Course, “Dry Eye Syndrome”.
Mentoring (Advisees):
12
2002-2003 Ozge Ilhan-Sarac, MD, former research fellow and currently
an academician ophthalmologist in Ankara, Turkey. Awarded
Turkish Scientific Council Clinician Scientist Scholarship for
“Keratoprothesis; Artificial Cornea” project.
2003-2004 John Kim, MD. Currently employed as the “Ophthalmology
Residency Program Director” at Albert Einstein Medical
Center.
2000-present Hatice Nida Sen, MD. Former medical student at the
Hacettepe University School of Medicine, Ankara-Turkey.
Currently The Fellowship Director of the Uveitis Clinical and
Research Fellowship at the National Institutes of Health.
2000-2001 Rana Altan-Yaycioglu, former Research and Clinical Fellow.
Currently an Associate Professor in Ophthalmology, Baskent
University, Adana-Turkey
2002-2002 Ama Doubrofi, Medical Student from Ghana, went into
ophthalmology residency in Ghana.
2003-2003 Justin Anderson, Medical Student in Texas, went into
ophthalmology residency at New York Eye and Ear
Infirmary, New York. Currently in private practice in TX.
2003 Dong Choe, Undergrad student. Johns Hopkins University.
2004-present Carly Benner, Undergrad student. Johns Hopkins University.
Accepted to Harvard Medical School.
2004-present Parag Parekh, MD, Resident at The Wilmer Eye Institute,
2005- A. E. Maumenee Reseach Grant Award for
“Subluxation of Suture Fixated Intraocular Lenses”
2007-Mitchell Prize 3rd
place.
2006- Richard Green Research Grant Award for “Unilateral
Pseudoexfoliation”. Both papers are in print.
2005-2006 Paul Botelho, Postdoctoral Fellow. Published “Botelho PJ,
Congdon NG, Handa JT, Akpek EK. Kertatoprosthesis in high-risk
pediatric corneal transplantation: first 2 cases. Arch Ophthalmol.
2006 Sep;124(9):1356-7”
2006-present Anita Gupta, Resident at The Wilmer Eye Institute, 2007
2007-Julia Haller Research Award for “Occult Thyroid Eye
Disease in Patients Presenting with Dry Eye Symptoms”.
Paper is in print.
2005-present Alena Klimava, Medical student, Johns Hopkins University
Currently a resident in ophthalmology, UCSF. Published
“Akpek EK, Klimava A, Thorne JE, et al. Evaluation dry eye
patients for associated medical conditions. Cornea.
2009;28:493-7.”
2006-2007 Marco Coassin, postdoctoral fellow. Worked on etiology of
artificial cornea failure. Published “Coassin M, Zhang C, Green WR, Aquavella JV, Akpek EK. Histopathologic and immunologic
13
aspects of aplhacor corneal failure. Am J Ophthalmol. 2007
Nov;144(5):699-704
2008-2010 Rohit Adyanthaya, Postdoctoral Fellow. Published Medical
management of acutely recurring pterygium with topical
mitomycin-C.
2008-present Shannon Shan, Medical Student, Johns Hopkins University
Published “Shan SJ, Wu EI, Akpek EK. Sterile corneal melt
after descemet stripping endothelial keratoplasty in patients
with previously undiagnosed Sjogren syndrome. Arch
Ophthalmol 2009; 127: 219-20.” Will be a resident at
Wilmer Eye Institute in July 2011.
2008-present Jonathan Tzu, Medical Student, Johns Hopkins University.
Currently a resident in ophthalmology at Bascom Palmer Eye
Institute. Worked on establishing a database for all patients
who underwent an artificial and donor corneal trnaplantation.
Published multiple papers, and also more are in press, see
CV.
2009-2010 Canan Asli Utine, MD, Assistant Professor of
Ophthalmology, Yeditepe University Eye Hospital, Istanbul,
Turkey. Published multiple papers and more are in press
currently. She is now in the process of being promoted to
Associate Professor at her institution.
2009-present Ferhina Ali, Medical Student, Johns Hopkins University.
Published “Ali FS, Akpek EK.Glaucoma and dry eye. Ophthalmology. 2009 Jun;116(6):1232.”
2010 Evelyn Tay, Medical Student, Singapore. Published “Tay E, Utine
CA, Akpek EK. Cresenteric amniotic membrane grafting in keratoporsthesis-assoicated Corneal Melt. Arch Ophthalmol. 2010
Jun;128(6):779-82.”
2009-present Ramya Swamy, MD, Medical Student, Johns Hopkins
University. Worked on Sjogren’s Syndrome related dry eye
trials. Has several papers in press, see CV. Will be an
ophthalmology resident at Doheny Eye Institute, CA in July
2011.
2010-present Adrian Dokey, BS, currently Medical Student, Johns
Hopkins University. Worked on establishing a database for
all dry eye patients with Sjogren’s Syndrome. Several papers
as well as a book chapter are in press currently, see CV. Will
be an ophthalmology resident at Wilmer in July 2012.
Editorial Activities:
1998-present Scientific Reviewers’ Board, Ophthalmology
2001-present Ad Hoc Reviewer, Archives of Ophthalmology
14
2001-present Ad Hoc Reviewer, British Journal of Ophthalmology
2003-present Ad Hoc Reviewer, Current Eye Research
2003-present Ad Hoc Reviewer, American Journal of Ophthalmology
2003-present Ad Hoc Reviewer, Ophthalmic Epidemiology
2003-present Ad Hoc Reviewer, BMC Ophthalmology
2003-present Ad Hoc Reviewer, Investigative Ophthalmology and
Visual Sciences
2003-present Ad Hoc Reviewer, Progress in Retinal and Eye Research
2004-present Ad Hoc Reviewer, Journal of Ocular Inflammation and
Immunology
2004-present Ad Hoc Reviewer, Cornea
2005-present Editorial Board Member, Current Drug Therapy
2006-present Ad Hoc Reviewer, New England Journal of Medicine
2006-present Ad Hoc Reviewer, Neuro-ophthalmology
2007-present Editorial Board Member, Contemporary Ophthalmology
2007-present Ad Hoc Reviewer, Drugs & Aging Journal
2008-present Editorial Board Member, Advances in Therapy
2009-present Editorial Board Member, Turkiye Klinikleri Dergisi
2009-present Reviewing Editor, Journal Ocular Immunology and
Inflammation
2009-present Editorial Board Member, Journal of European Medical
Students Association
2009-present Editorial Board Member, Advanced Ocular Care
2010-present Editorial Board Member, Marmara Medical Journal
CLINICAL ACTIVITIES
Certification:
1991-present Medical License, Turkey (91AB064)
1995-present Diplomat of the Turkish Board of Ophthalmology
1997-present Visex PRK-PTK Certificate
1998-present Chiron Vision LASIK Certification
2002-present Medical License, Maryland (00D58519)
2003-present ArgusConnect (Alphacorkeratoprosthesis) Accreditation
Certificate
Service Responsibilities:
Holds clinics, two full days per week, at the Cornea Service of the Wilmer Eye Institute.
One day per week is devoted to the “Ocular Surface Diseases and Dry Eye Clinic” where
patients with allergic and immunologic diseases of the ocular surface (scleritis, keratitis,
cicatrizing conjunctivitis, dry eye and ocular surface diseases associated with
autoimmune and collagen vascular disorders) are managed. Dr. Akpek is the Director of
the Ocular Surface Clinic. The other day id devoted to surgical patients. Dr. Akpek
performs various surgeries, one day per week, to reconstruct the ocular surface in patients
with destructive anterior segment problems including lamellar and penetrating
keratoplasty, amniotic membrane and scleral grafting, limbal stem cell transplantation
15
and artificial cornea surgery. Dr. Akpek is the only faculty member who performs
artificial corneal surgeries. Dr. Akpek receives numerous patient referrals from within as
well as outside the United States who need these surgeries.
Dr. Akpek spends two days per week doing laboratory and clinical research as well as
teaching.
Dr. Akpek also participates in the Sjogren’s Syndrome Center at the Bayview Medical
Center and holds clinics one day per month. Dr. Akpek is the Associate Director of the
Center.
ORGANIZATIONAL ACTIVITIES
Professional Societies:
1996-present American Academy of Ophthalmology
1997-2009 Turkish-American Ophthalmologic Society
1996-1999 American Society of Cataract and Refractive Surgery
1996-1999 Contact Lens Association of Ophthalmologists
1997-2000 Massachusetts Medical Society
1997-present Association for Research in Vision and Ophthalmology
1997-2000 American Medical Association
1997-present International Ocular Inflammation Society
1998-present The Cornea Society (formerly Castroviejo Society)
1998-present American Uveitis Society
2001-2005 Pan American Association of Ophthalmology
2003- present International Society of Dacryology and Dry Eye
2003-present Tear Film and Ocular Surface Society
2006- present Keratoprosthesis Study Group
2006-2009 President, Turkish American Ophthalmological Society
Session Chair:
2000 Moderator; session title “Genetics,” 3rd International
Conference on Cornea, Eye Banking and External
Diseases, International Federation of Eye Banks, Istanbul,
Turkey, July 2000.
2003 Moderator; session title “Regulatory Mechanisms of Ocular
Surface Inflammation,” ARVO, Fort Lauderdale, FL, May
2003.
2004 Moderator, session title “Advances in Keratoplasty”,
AfroAsian Ophthalmological Meeting, Istanbul, Turkey
2004.
2004 Co-Moderator, session title “Paper Presentations in
Anterior Segment Diseases ”, AfroAsian Ophthalmological
Meeting, Istanbul, Turkey 2004.
2007 Session Chair; poster session on tear film. 5th International
Conference on the Tear Film and Ocular Surface: Basic
Science and Clinical Relevance. September, 2007, Italy.
2006-present Chair, Ocular Surface Diseases and Dry Eye Grandrounds,
held in the month of May every year, Baltimore, Maryland.
16
2010 Moderator, session title “Ocular Surface Disease: Clinical
Aspects”, International Ocular Surface Society Meeting,
Fort Lauderdale, May 1, 2010
2010 Session Chair; Sjogrens’ Syndrome. 6th International
Conference on the Tear Film & Ocular Surface: Basic
Science and Clinical Relevance. Florence, Italy
Consultantship:
2005-2006 Consultant’s Agreement, W. L. Gore & Associates, Inc.,
“Keratoprosthesis: Artificial Cornea.”
2007-2010 Consultant’s Agreement, Lux Biosciences, “Voclosporin
Treatment of Sjogren’s Syndrome Associated Dry Eye”.
2008-present Consultant’s Agreement, Pfizer, Topical
Immunosuppression in the Treatment of Dry Eye
Syndrome”.
Patents:
2008 Novel Keratoprosthesis. Co-Inventor. US Patent
Application No. 2008/0255,663. Title: Artificial Cornea
and Method of Making Same.
Administrative Responsibilities
2003-2006 Delegate, Uveitis Self Assessment Committee, American
Academy of Ophthalmology.
2003-2008 Wilmer Eye Institute, Cornea and External Diseases
Fellowship program description and curricular activities
(created and responsible for updating as needed) and
Fellows’ Advocate
2004-2010 Co-Director, Ophthalmology Clerkship Program, Johns
Hopkins Medical School
2005 Mind/Brain Content Committee, Johns Hopkins University,
Medical School
2005-present Member, Mitchell Prize Committee, a selection committee to
fund outstanding Wilmer resident research
2005-present Associate Professor Promotion Committee, The Wilmer Eye
Institute, Johns Hopkins Medical School
2005-present Clinical Practice Association Committee, The Wilmer Eye
Institute.
2007-2009 President, Turkish-American Ophthalmologists Society.
2009-present Member of Medical & Scientific Advisory Board, Tear Film
& Ocular Surface Society
2010-present Director, Cornea and External Disease Clinical Fellowship
Program, The Wilmer Eye Institute, Johns Hopkins
University Medical School.
17
2010-present Representative, Medical School Council, Johns Hopkins
University School of Medicine.
RECOGNITION
Honors and Awards:
1998 Immunology Award, Ocular Immunology and Uveitis
Service, Massachusetts Eye and Ear Infirmary, Harvard
Medical School
2000 Cora Verhagen Immunology Prize, Association for
Research in Vision and Ophthalmology 2000, Fort
Lauderdale, FL, for “Induction of Peripheral Ulcerative
Keratitis by Adoptive Transfer of Human Corneal Antigen-
Synthesized T Lymphocytes”
2001 Honored by Turkish-American Ophthalmologists Society,
November 2001, New Orleans
2003 Recipient of “Daughters of Ataturk Award”, for
outstanding international Turkish woman.
2004 Achievement Award, America Academy of
Ophthalmology.
2004 Selected to be included in “Guide to America’s Top
Ophthalmologists” by Consumers’ Research Council of
America.
2005 Resident Advocate Award, The Wilmer Eye Institute
Residency Training Program
2007 Selected to be included in “Guide to America’s Top
Ophthalmologists” by Consumers’ Research Council of
America.
2008 Neil R. Miller Full Time Faculty Medical Student Teaching
Award, Johns Hopkins Medical School.
2009 Selected to be included in “Best Doctors in America” by
Consumers’ Research Council of America.
2010 Selected to be included in “Best Doctors in America” by
Consumers’ Research Council of America.
Invited Talks:
1. Foster CS, Akpek EK. Episcleritis and Scleritis Course. Presented by invitation at
the XIth European Society of Ophthalmology Meeting, Budapest, Hungary, June
1997.
2. Akpek EK. Scleritis-Episcleritis-Uveitis Course. Presented by invitation at the
Annual Meeting of American Society of Ophthalmic Registered Nurses, in
association with 102nd American Academy of Ophthalmology Meeting, New
Orleans, November 1998.
18
3. Akpek EK, Foster CS. Limbal stem cell transplantation. Presented by invitation at
the Annual Fellows’ Course of Massachusetts Eye and Ear Infirmary, Harvard
Medical School, “Surgical Advances in Ophthalmology,” Boston, February 1998.
4. Akpek EK. Ocular surface malignancies presenting as chronic conjunctivitis:
sasquerade syndrome. Presented by invitation at the Cornea Day, The Wilmer Eye
Institute, Johns Hopkins Hospital, Baltimore, January 1999.
5. Akpek EK. Corneal gene expression and graft rejection. Presented by invitation at
the session entitled “Genetics,” 3rd International Conference on Cornea, Eye
Banking and External Diseases, International Federation of Eye Banks, Istanbul,
Turkey, July 2000.
6. Akpek EK. Refractive surgery marketing. Presented by invitation at the Current
Concepts in Ophthalmology, Baltimore, December 2000.
7. Akpek EK. Therapeutic algorithm for herpes virus keratitis. Presented by invitation
at the session entitled “Advances in Ocular Infectious Diseases Symposium,” XIII
Congress of the European Society of Ophthalmology, Istanbul, Turkey, June 2001.
8. Akpek EK. Biology of limbal stem cells and therapeutic applications. Presented by
invitation at the session entitled “Ocular Surface Disease and Its Management,” XIII
Congress of the European Society of Ophthalmology, Istanbul, Turkey, June 2001.
9. Akpek EK. Scleritis and systemic disease association. Presented by invitation as a
“Keynote Lecture” at the Turkish-American Ophthalmologists Society Meeting in
conjunction with American Academy of Ophthalmology Meeting, New Orleans,
November 2001.
10. Akpek EK. Clinical uses of topical cyclosporin A. Presented by invitation at the
session entitled “Cyclosporin,” 7th Congress of the International Ocular
Inflammation Society, Padua, Italy, May 2003.
11. Akpek EK. Keratoprosthesis: Patient Selection, Surgical Technique and Outcomes”,
AfroAsian Ophthalmology Meeting, Istanbul Turkey, June 2004.
12. Akpek EK. Masquarede syndromes: Tis or Thisn’t. Second Update on Ocular
Infectious Disease. May 21-22, 2004. Johns Hopkins Hospital, Baltimore, Maryland.
13. Akpek EK. Scleritis and systemic disease association. Georgetown University
Grand Rounds, November 2004, Washington DC.
14. Akpek EK. Serpiginous choroiditis and Multifocal Choroiditis: An Evidence-Based
Review of Treatment, Uveitis Symposium, Annual American Academy of
Ophthalmology Meeting, New Orleans, 2004.
15. Akpek EK. Stevens Johnson Syndrome and Graft versus Host Disease. Uveitis
Subspecialty Day, Annual American Academy of Ophthalmology Meeting, Chicago,
2005.
16. Akpek EK. “Update in cornea and external disease.” Women in Ophthalmology
Annual Retreat, Aspen, CO, July 2005.
17. Akpek EK. Ocular Surface Disease. A 2-hour course. Optometric Continuing
Education Program, Maryland Optometric Association, June 5, 2005, Baltimore,
MD.
18. Akpek EK. Cataract surgery in uveitis patients. TOD-AAO Panel at the TOD 39th
Annual National Ophthalmology Congress, September 2005 Turkey.
19
19. Roh M, Akpek EK. Basic ophthalmological examination. TOD-AAO Basic Skills
Course at the TOD 39th
Annual National Ophthalmology Congress, September 2005,
Antalya, Turkey.
20. Akpek EK. Keratoprosthesis for pediatric cases. 6th KPro Study Group Meeting,
Miami, Florida, May 2006.
21. Akpek EK. Current concepts on dry eye diagnosis and treatment. Maryland Society
of Eye Physicians and Surgeons. October 13, 2006, Baltimore, MD.
22. Akpek EK. Keratoprosthesis in High Risk Corneal Transplantation Patients.
Advances in Anterior Segment Surgery. Sponsored by U.S. Army Medical
Command, hosted by Walter Reed Army Medical Center, Uniformed Services
University of the Health Sciences. March, 2007, Bethesda, MD.
23. Akpek EK. Management and Update of Dry Eye Inflammation. Current Concepts in
Ophthalmology, A Forum for Global Ophthalmic Innovators Meeting, Cataract
Surgery-Cornea Session, April, 2007, Baltimore, MD.
24. Akpek EK. New Approaches to Ocular Surface Diseases. Advances in
Ophthalmology. Maryland Society of Eye Physicians and Surgeons, 2007 Annual
Scientific Assembly, May 2007, Baltimore, MD.
25. Akpek EK. Keratoprosthesis: History, Patient Selection, Techniques and Results.
Advances in Ophthalmology. Maryland Society of Eye Physicians and Surgeons
2007 Program for Ophthalmic Medical Personnel May 2007, Baltimore, MD.
26. Akpek EK. Dry eye and systemic disease association. 5th
International Conference
on the Tear Film and Ocular Surface: Basic Science and Clinical Relevance, Italy
September 2007.
27. Akpek EK. Dry eye syndrome and systemic disease association. Visiting
Professorship, University of Rochester Eye Institute, August, 2006.
28. Akpek EK. Keratoprosthesis: Current Techniques and Future Developments.
Visiting Professorship, Massachusetts Eye Research and Surgery Institution,
November 2007.
29. Akpek EK. Cataract Surgery in Patients with Uveitis. 23rd
Biennial Walter Reed
Ophthalmology Postgraduate Course and Alumni Meeting. Bethesda, Maryland,
March 2008.
30. Akpek EK. 25th
Annual Wilmer Nursing Conference, Baltimore, MD, May 2008,
Changing Patterns of Contact Lens Related Infections.
31. Akpek EK. Tidewater Ophthalmology and Otolaryngology Meeting, Virginia
Beach, May 2008. Dry Eye Syndrome: Any Relief in Sight?
32. Akpek EK. Keynote Speaker, Oculoplastics Session, Virginia Society of
Ophthalmology Meeting, Washington, DC, June 2008. Masquarede Syndromes: This
or Thisn’t.
33. Akpek EK. Combined penetrating keratoplasty with sutured intraocular lens
implantation. World Ophthalmology Congress, Hong Kong June 2008.
34. Akpek EK. Combined penetrating keratoplasty with sutured intraocular lens
implantation. RANZCO, Sidney, Australia, November 2008.
35. Akpek EK. Visiting Professor, Cornell-Weil University Medical School,
Department of Ophthalmology, “Dry Eye and Systemic Disease Association”, New
York, June, 2009.
20
36. Akpek EK. Invited Speaker, Systemic Diseases Session, “Dry Eye and Systemic
Disease Association”, IOIS, Prague, Check Republic, June 2009.
37. Akpek EK. Invited Speaker, Diseases of the Anterior Segment Session, “Maquarede
Syndromes: This or Thisn’t”, IOIS, Prague, Check Republic, June 2009.
38. Akpek EK. Visiting Professor, Diseases of the Ocular Surface Session, “Refractory
Dry Eye”, Yale Cornea Cataract Symposium, New Heaven, CT, October 2009
39. Akpek EK. Visiting Professor. New York Eye and Ear, “Keratoproshesis: History,
Current Techniques and Future Devices” November 2009.
40. Akpek EK. Visiting Professor. 55th Annual Rochester Ophthalmology Conference.
Dry Eye and Systemic Disease Association. March 2010.
41. Akpek EK. Predictors of Sjogren’s syndrome in patients with dry eye. 6th
International Conference on the Tear Film and Ocular Surface: Basic Science and
Clinical Relevance, Italy September 2007.
42. Akpek EK. Tear Film & Ocular Surface Society: A Report from the International
Workshop on Meibomian Gland Dysfunction. European Association for Vision and
Eye Research, Crete, Greece, October 2010.
43. Akpek EK. What lies ahead – Single Piece Keratoprosthesis. 25th
APAO, Beijing,
China, September 2010.
44. Akpek EK. Visiting Professor. George Washington University, “Keratoprosthesis:
Future Considerations” September 2010.
Invited Reviews, Editorials:
1- Akpek EK, Ilhan-Sarac O. New treatments in serpiginous choroiditis. Curr Opin
Ophthalmol, 2003 ;14:128-31.
2- Ilhan-Sarac O, Akpek EK. Atopic keratoconjunctivitis: Current Thinking and
Treatment, International Ocular Inflammation and Immunology Society Newsletter,
summer 2004.
3- Ilhan-Sarac O, Akpek EK. Current concepts and techniques in keratoprosthesis. Curr
Opin Ophthalmol 2005;16:246-50.
4- Suh LH, Akpek EK. Stevens Johnson Syndrome. International Ocular
Inflammation and Immunology Society Newsletter, summer 2005.
6- Reznik J, Kim A, Dekhayser J, Akpek EK. Gatifloxacin 0.3% Ophthalmic Solution in
the Treatment of Bacterial Keratitis. Expert Rev Ophthalmol 2008;3:21-7.
7- Akpek EK. Dry Eye on the Rise. Editorial. Eyeworld, 2007.
8- Lekhanont K, Srikumaran D, Akpek EK. Pediatric keratoplasty. Expert Rev
Ophthalmol 2008;3:655-663.
9- Akpek EK. The Art Behind the Science of Dry-Eye Detection. Editorial. Rev
Ophthalmol November 2008.
10- Akpek EK, Barber LG, Perry HD, Pflugfelder SC, Wilson SE. Is there a dry eye in
the house? A science Writer’s Guide to Dry Eye. Sponsored by American Academy of
Ophthalmology, 2006.
11- McDonald MB, Akpek EK, Karpecki P, Pflugfelder SC. The VIEW II: Halting
Progression of Dry Eye Disease. SynerMed® Communications Proceedings
TM
Newsletter. June 2009.
13- Utine CA, Akpek EK. What ophthalmologists should know about Sjögren’s
syndrome. European Ophthalmic Review vol 4, 2010;1-6.
21
14- Utine CA, Stern M, Akpek EK. Clinical Review: Topical Ophthalmic Use of
Cyclosporin A. Ocul Immunol Inflamm. 2010 Aug 25.
Other educational activities
2010 Member, the Uveitis section of the Practicing Ophthalmologists
Curriculum, for the MOC Exam Study Kit. American Academy of
Ophthalmology, as representative of the American Uveitis Society
2010 Meibomian Gland Disease Committee, Tear Film and Ocular Surface
Society